• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.

作者信息

D'Amico Anthony V

机构信息

Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.

出版信息

J Clin Oncol. 2014 Feb 1;32(4):362-4. doi: 10.1200/JCO.2013.53.9528. Epub 2013 Dec 16.

DOI:10.1200/JCO.2013.53.9528
PMID:24344221
Abstract
摘要

相似文献

1
US Food and Drug Administration approval of drugs for the treatment of prostate cancer: a new era has begun.美国食品药品监督管理局批准用于治疗前列腺癌的药物：一个新时代已经开启。
J Clin Oncol. 2014 Feb 1;32(4):362-4. doi: 10.1200/JCO.2013.53.9528. Epub 2013 Dec 16.
2
[Novel drugs provide better therapy for prostate cancer].新型药物为前列腺癌提供更好的治疗方法
Duodecim. 2013;129(9):923-30.
3
New prostate cancer drugs hold promise.新型前列腺癌药物有望取得成效。
Cancer. 2013 Jan 15;119(2):247-8. doi: 10.1002/cncr.27943.
4
A renaissance in the medical treatment of advanced prostate cancer.晚期前列腺癌治疗的复兴。
Oncology (Williston Park). 2010 Dec;24(14):1308-13, 1318.
5
Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer.骨骼转移及抗雄激素药物和骨靶向药物对去势抵抗性前列腺癌患者的影响。
Cancer Treat Rev. 2016 Mar;44:61-73. doi: 10.1016/j.ctrv.2016.02.002. Epub 2016 Feb 12.
6
Clinical development of novel therapeutics for castration-resistant prostate cancer: historic challenges and recent successes.新型抗去势治疗前列腺癌疗法的临床研发：历史挑战与近期成功。
CA Cancer J Clin. 2012 Sep-Oct;62(5):299-308. doi: 10.3322/caac.21141. Epub 2012 Apr 24.
7
New treatment options for patients with metastatic castration-resistant prostate cancer.转移性去势抵抗性前列腺癌患者的新治疗选择。
Cancer Treat Rev. 2012 Aug;38(5):340-5. doi: 10.1016/j.ctrv.2011.07.007. Epub 2011 Sep 23.
8
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.降低转移性去势抵抗性前列腺癌的骨相关事件发生率
Oncology (Williston Park). 2015 Jun;29(6):416-23.
9
Management of docetaxel failures in metastatic castrate-resistant prostate cancer.转移性去势抵抗性前列腺癌中多西他赛治疗失败的管理。
Urol Clin North Am. 2012 Nov;39(4):583-91. doi: 10.1016/j.ucl.2012.07.013. Epub 2012 Aug 29.
10
[Strategy in advanced castration-resistant prostate cancer].[晚期去势抵抗性前列腺癌的治疗策略]
Bull Cancer. 2012 Jul;99 Suppl 1:S37-45. doi: 10.1684/bdc.2012.1562.

引用本文的文献

1
Which Way to Choose for the Treatment of Metastatic Prostate Cancer: A Case Report and Literature Review.转移性前列腺癌的治疗该如何选择：一例病例报告及文献综述
Front Oncol. 2021 Apr 26;11:659442. doi: 10.3389/fonc.2021.659442. eCollection 2021.
2
Balancing the stability and drug activation in adaptive nanoparticles potentiates chemotherapy in multidrug-resistant cancer.在适应性纳米颗粒中平衡稳定性和药物激活可增强对多药耐药癌症的化疗效果。
Theranostics. 2021 Feb 19;11(9):4137-4154. doi: 10.7150/thno.54066. eCollection 2021.
3
Prognostic value of ECOG performance status and Gleason score in the survival of castration-resistant prostate cancer: a systematic review.
ECOG 体能状态和 Gleason 评分对去势抵抗性前列腺癌生存预后的价值：一项系统综述。
Asian J Androl. 2021 Mar-Apr;23(2):163-169. doi: 10.4103/aja.aja_53_20.
4
Imipramine Inhibits Migration and Invasion in Metastatic Castration-Resistant Prostate Cancer PC-3 Cells via AKT-Mediated NF-κB Signaling Pathway.丙咪嗪通过 AKT 介导的 NF-κB 信号通路抑制转移性去势抵抗性前列腺癌 PC-3 细胞的迁移和侵袭。
Molecules. 2020 Oct 11;25(20):4619. doi: 10.3390/molecules25204619.
5
Application of Phage-Displayed Peptides in Tumor Imaging Diagnosis and Targeting Therapy.噬菌体展示肽在肿瘤成像诊断与靶向治疗中的应用
Int J Pept Res Ther. 2021;27(1):587-595. doi: 10.1007/s10989-020-10108-5. Epub 2020 Sep 3.
6
Longitudinal model-based meta-analysis for survival probabilities in patients with castration-resistant prostate cancer.基于纵向模型的前列腺癌去势抵抗患者生存概率的荟萃分析。
Eur J Clin Pharmacol. 2020 Apr;76(4):589-601. doi: 10.1007/s00228-020-02829-9. Epub 2020 Jan 10.
7
Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy: Treatment Patterns From the PROXIMA Prospective Registry.先前接受过基于多西他赛化疗的转移性去势抵抗性前列腺癌：来自PROXIMA前瞻性注册研究的治疗模式
J Glob Oncol. 2018 Sep;4:1-12. doi: 10.1200/JGO.18.00009.
8
Role of chemotherapy in prostate cancer.化疗在前列腺癌中的作用。
Asian J Androl. 2018 May-Jun;20(3):221-229. doi: 10.4103/aja.aja_40_17.
9
ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.ROS 响应型多前药纳米粒子用于触发药物递送和有效癌症治疗。
Adv Mater. 2017 Sep;29(33). doi: 10.1002/adma.201700141. Epub 2017 Jul 6.
10
Risk of skeletal related events among elderly prostate cancer patients by site of metastasis at diagnosis.老年前列腺癌患者诊断时转移部位与骨相关事件的风险
Cancer Med. 2016 Nov;5(11):3300-3309. doi: 10.1002/cam4.914. Epub 2016 Oct 11.